z-logo
Premium
Identification of S ola l 4 as B et v 1 homologous pathogenesis related‐10 allergen in tomato fruits
Author(s) -
Wangorsch Andrea,
Jamin Annette,
Foetisch Kay,
Malczyk Anna,
Reuter Andreas,
Vierecke Sabine,
Schülke Stefan,
Bartel Detlef,
Mahler Vera,
Lidholm Jonas,
Vieths Stefan,
Scheurer Stephan
Publication year - 2015
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201300620
Subject(s) - allergen , pollen , immunoglobulin e , allergy , immunology , pathogenesis , cross reactivity , recombinant dna , biology , botany , antibody , cross reactions , biochemistry , gene
Scope The aim was to investigate the potential contribution of a major birch pollen B et v 1‐homologous allergen to birch pollen‐associated tomato fruit allergy. Methods and results Two isoforms of a B et v 1‐homologous protein (designated S ola l 4) from tomato fruit were identified by c DNA ‐cloning and produced as recombinant proteins. Allergen‐specific I g E levels to tomato, birch pollen, B et v 1, and S ola l 4 were determined in birch pollen allergic patients with allergy or tolerance to tomato. Sola l 4 was recognized in 76% of birch/tomato allergic patients, while tomato‐ and B et v 1‐specific I g E was detectable in 64% and 81% of sera. Almost all patients sensitized to B et v 1 reacted with S ola l 4. Both Sola l 4 isoforms displayed allergenic potency and I g E ‐cross‐reactivity with B et v 1 as investigated by competitive ELISA and in vitro mediator release assay. Nevertheless, the reactivity pattern of patients' sera was diverse. Conclusion Sola l 4, a novel pathogenesis related‐10 protein, qualifies as major allergen in tomato fruits. Data suggest Sola l 4 as class II allergen. Ig E ‐testing using S ola l 4 showed low clinical specificity, but high sensitivity in tomato allergic patients and will further improve component‐resolved allergy diagnosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here